GLOBAL NAUSEA AND VOMITING TREATMENT MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Sep 2019 100

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Description

Scope of the Report:
The global Nausea And Vomiting Treatment market is valued at 4435.7 million USD in 2018 and is expected to reach 5646.8 million USD by the end of 2024, growing at a CAGR of 6.2% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nausea And Vomiting Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Nausea And Vomiting Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nausea And Vomiting Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
- Merck & Co. Inc.
- Taiji group
- Kyowa Kirin
- Helsinn Group
- Teva Pharmaceutical Industries Ltd.
- Unimed Pharmaceuticals (AbbVie Inc.)
- Heron Therapeutics
- Qilu Pharma
- Sanofi
- Novartis
- Atnahs Pharma UK Limited
- Tesaro
- Mylan
- Duchesnay

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Serotonin Receptor Antagonist
- Neurokinin NK1 Receptor Antagonist
- Other

Serotonin Receptor Antagonist had the biggest market share of 61% in 2018.

Market Segment by Applications, can be divided into
- CINV
- PONV
- Motion Sickness
- Pregnancy
- Others

CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.

Table of Contents

Related reports :

(Feb 20)

Market Overview The global NK Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, wit...

(Feb 20)

Market Overview The global Natural Killer (NK) Cell Therapeutics market size is expected to gain market growth in the forecas...

(Feb 20)

Market Overview The global Neuroprotective Drugs market size is expected to gain market growth in the forecast period of 2020...

(Feb 20)

Market Overview The global Nifedipine market size is expected to gain market growth in the forecast period of 2020 to 2025, w...

(Feb 20)

Market Overview The global Metacycline market size is expected to gain market growth in the forecast period of 2020 to 2025, ...

(Feb 20)

Market Overview The global Metabotropic Glutamate Receptor market size is expected to gain market growth in the forecast peri...

GLOBAL NAUSEA AND VOMITING TREATMENT MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy